James C. Czirr
2011
In 2011, James C. Czirr earned a total compensation of $3.2M as Executive Chairman and Director at Galectin Therapeutics.
Compensation breakdown
| Option Awards | $3,036,375 |
|---|---|
| Salary | $92,502 |
| Other | $39,154 |
| Total | $3,168,031 |
Czirr received $3M in option awards, accounting for 96% of the total pay in 2011.
Czirr also received $92.5K in salary and $39.2K in other compensation.
Rankings
In 2011, James C. Czirr's compensation ranked 1,998th out of 10,747 executives tracked by ExecPay. In other words, Czirr earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,998 out of 10,747 | 81st |
Division Manufacturing | 721 out of 3,960 | 82nd |
Major group Chemicals And Allied Products | 154 out of 1,033 | 85th |
Industry group Drugs | 87 out of 781 | 89th |
Industry Pharmaceutical Preparations | 73 out of 571 | 87th |
Source: SEC filing on April 12, 2013.
Czirr's colleagues
We found four more compensation records of executives who worked with James C. Czirr at Galectin Therapeutics in 2011.